Cabaletta Bio, Inc. (CABA) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
About Cabaletta Bio, Inc.
Cabaletta Bio, Inc. is led by CEO Steven A. Nichtberger, publicly traded since 2019.
Cabaletta Bio, Inc. (CABA) stock trades at $1.47 with a market capitalization of $249.23M. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.27, reflecting a net loss over the last twelve months, price-to-book of 1.44, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.40 and $4.23, and currently trades 65.2% below its 52-week high.
On profitability, Cabaletta Bio, Inc. generates a return on equity (ROE) of -128.27% (negative, reflecting a net loss), return on capital employed of -85.56%.
Cabaletta Bio, Inc. by the numbers, 2017–2025
Between 2017 and 2025 Cabaletta Bio, Inc. reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit was $-168.0M in 2025.
On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-182.0M.
Borrowings stand at $27.0M, cash from operations was $-131.0M in the latest year, positive in 0 of the last 9.
Return on equity has averaged -68.9% over five years, and was -150.0% in the most recent year.
The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
Cabaletta Bio, Inc. (CABA) — frequently asked questions
What is Cabaletta Bio, Inc. (CABA) stock price today?
Cabaletta Bio, Inc. (CABA) is currently trading at $1.47, down 3.29% today.
What is CABA P/E ratio?
Cabaletta Bio, Inc.'s P/E ratio is -1.27. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is CABA return on equity (ROE)?
Cabaletta Bio, Inc.'s return on equity (ROE) is -128.27%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Cabaletta Bio, Inc.'s market cap?
Cabaletta Bio, Inc. has a market capitalization of $249.23M.
Does CABA pay a dividend?
Cabaletta Bio, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does CABA carry?
Cabaletta Bio, Inc. has a debt-to-equity ratio of 0.12. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is CABA's profit margin?
Cabaletta Bio, Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.
What sector is CABA in?
Cabaletta Bio, Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is CABA listed on?
Cabaletta Bio, Inc. trades on NASDAQ under the ticker CABA.
What is CABA's 52-week range?
Over the last year Cabaletta Bio, Inc. has traded between $1.40 and $4.23.
Related Healthcare Stocks
Popular Stocks
Screens CABA currently matches
On the figures above, Cabaletta Bio, Inc. passes the filters for 4 of our ready-made screens, among them Penny Stocks, Stocks Under $5, Stocks Under $10. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.